Media Coverage: 1,800 People Undergo Preemptive Pharmacogenomics Testing in Pilot

Our programme, Precision Health Research, Singapore ↗ (opens in new tab) (PRECISE), is supporting clinical implementation pilots which facilitate the incorporation of genetic/genomic tests into clinical pathways to improve patient outcomes.

One such pilot is the Pre-emptive Pharmacogenomic Testing (PPGx) clinical implementation pilot which aims to investigate the impact of incorporating pre-emptive multi-drug/multi-gene PPGx testing as a precision medicine clinical tool in routine clinical practice, for appropriate prescribing to maximise the benefits of treatment while minimising side effects.

Read more about the study in the coverage by Lianhe Zaobao below:

• 1800 people join pilot study research on Pharmacogenomics ↗ (opens in new tab)

• Volunteer: Pilot study on Pharmacogenomics is beneficial to all ↗ (opens in new tab)